A complete review of migraine

Ommurugan Balaji, D. Amita Priya, Kurady Laxminarayana Bairy

Research output: Contribution to journalReview article

Abstract

Migraine characterized by recurrent headaches present with aura or without aura. Various treatment modalities ranging from 5-hydroxytryptamine 1B/1D agonists, non-steroidal anti-inflammatory drugs to steroids are available for acute treatment of migraine. Prophylaxis for chronic cases is usually with β blockers, calcium channel blockers, and antiepileptics. Even many nutraceutical preparations are helpful in migraine including riboflavin, vitamin b12. This review focuses on the newer agents available for treatment of migraine with some sight into their clinical trials.

Original languageEnglish
Pages (from-to)57-62
Number of pages6
JournalAsian Journal of Pharmaceutical and Clinical Research
Volume10
Issue number10
DOIs
Publication statusPublished - 01-10-2017
Externally publishedYes

Fingerprint

Migraine Disorders
Epilepsy
Riboflavin
Calcium Channel Blockers
Vitamin B 12
Dietary Supplements
Anticonvulsants
Headache
Serotonin
Anti-Inflammatory Agents
Therapeutics
Steroids
Clinical Trials
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)

Cite this

Balaji, Ommurugan ; Amita Priya, D. ; Bairy, Kurady Laxminarayana. / A complete review of migraine. In: Asian Journal of Pharmaceutical and Clinical Research. 2017 ; Vol. 10, No. 10. pp. 57-62.
@article{0f51e843e96c4088bbeb5359cce15365,
title = "A complete review of migraine",
abstract = "Migraine characterized by recurrent headaches present with aura or without aura. Various treatment modalities ranging from 5-hydroxytryptamine 1B/1D agonists, non-steroidal anti-inflammatory drugs to steroids are available for acute treatment of migraine. Prophylaxis for chronic cases is usually with β blockers, calcium channel blockers, and antiepileptics. Even many nutraceutical preparations are helpful in migraine including riboflavin, vitamin b12. This review focuses on the newer agents available for treatment of migraine with some sight into their clinical trials.",
author = "Ommurugan Balaji and {Amita Priya}, D. and Bairy, {Kurady Laxminarayana}",
year = "2017",
month = "10",
day = "1",
doi = "10.22159/ajpcr.2017.v10i10.19207",
language = "English",
volume = "10",
pages = "57--62",
journal = "Asian Journal of Pharmaceutical and Clinical Research",
issn = "0974-2441",
publisher = "Innovare Academics Sciences Pvt. Ltd",
number = "10",

}

A complete review of migraine. / Balaji, Ommurugan; Amita Priya, D.; Bairy, Kurady Laxminarayana.

In: Asian Journal of Pharmaceutical and Clinical Research, Vol. 10, No. 10, 01.10.2017, p. 57-62.

Research output: Contribution to journalReview article

TY - JOUR

T1 - A complete review of migraine

AU - Balaji, Ommurugan

AU - Amita Priya, D.

AU - Bairy, Kurady Laxminarayana

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Migraine characterized by recurrent headaches present with aura or without aura. Various treatment modalities ranging from 5-hydroxytryptamine 1B/1D agonists, non-steroidal anti-inflammatory drugs to steroids are available for acute treatment of migraine. Prophylaxis for chronic cases is usually with β blockers, calcium channel blockers, and antiepileptics. Even many nutraceutical preparations are helpful in migraine including riboflavin, vitamin b12. This review focuses on the newer agents available for treatment of migraine with some sight into their clinical trials.

AB - Migraine characterized by recurrent headaches present with aura or without aura. Various treatment modalities ranging from 5-hydroxytryptamine 1B/1D agonists, non-steroidal anti-inflammatory drugs to steroids are available for acute treatment of migraine. Prophylaxis for chronic cases is usually with β blockers, calcium channel blockers, and antiepileptics. Even many nutraceutical preparations are helpful in migraine including riboflavin, vitamin b12. This review focuses on the newer agents available for treatment of migraine with some sight into their clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=85030539232&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030539232&partnerID=8YFLogxK

U2 - 10.22159/ajpcr.2017.v10i10.19207

DO - 10.22159/ajpcr.2017.v10i10.19207

M3 - Review article

VL - 10

SP - 57

EP - 62

JO - Asian Journal of Pharmaceutical and Clinical Research

JF - Asian Journal of Pharmaceutical and Clinical Research

SN - 0974-2441

IS - 10

ER -